A Study to Evaluate the Neuro-embolic Consequences of TAVR

NCT02073864 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2015-08-27

No results posted yet for this study

Summary

A prospective, multi-center study to evaluate the neuro-embolic consequences of Transcatheter Aortic Valve Replacement (TAVR)

Conditions

  • Aortic Valve Stenosis

Sponsors & Collaborators

  • Keystone Heart

    lead INDUSTRY

Principal Investigators

  • Alexandra Lansky, Md. · Yale Cardiovascular Clinical Research

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2015-06-30
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02073864 on ClinicalTrials.gov